摘要
采用尼莫地平制剂的部颁试行标准和转正标准及德国拜耳公司尼莫通标准中的溶出度测定方法对国产尼莫地平片（２０ｍｇ／片）、尼莫通片（３０ｍｇ／片）和“普利”尼莫地平胶囊（２０ｍｇ／粒）３种药品进行溶出度的对比实验。结果发现采用德国拜耳公司尼莫通标准测定尼莫地平制剂的体外溶出度具有更好的体内外相关性。
出处
《中国新药杂志》
CAS
CSCD
1997年第S1期3-5,共3页
Chinese Journal of New Drugs
同被引文献17
-
1Alekha K Dash,Greggrey C Cudworth.Therapeutic Applications of Implantable Drug Delivery System[J].Journal of Pharmacological and Toxicological Method,1998,40(1):1-12.
-
2Rakesh K Jain.Delivery of molecular and cellular medicine to solid tumors[J].Journal of Controlled Release,1998,53(1):49-67.
-
3Waggoner PJ.Release Kinetics of Protein Loaded Biodegradable Polymer Fibers[D].M.S.Thesis,University of Texas Arlington,December 2000.7.
-
4Torchilin VP.Drug targeting[J].European Journal of Pharmaceutical Sciences,2000,11(Supl2):S81-S91.
-
5Van Dijk M,van Diest PJ,Smit TH,et al.Four-year follow-up of poly-L-lactic Acid cages for lumbar interbody fusion in goats[J].Jounal of Long Term Eff Med Implants,2005,15(2):125-138.
-
6Gao C,Gao J,You X,et al.Fabrication of calcium sulfate/PLLA composite for bone repair.J Biomed Mater Res A,2005,73(2):244-253.
-
7Yang F,Xu CY,Kotaki M,et al.Characterization of neural stem cells on electrospun poly (L-lactic acid) nanofibrous scaffold[J].J Biomater Sci Polym Ed,2004,15(12):1483-1497.
-
8Mikos Antonios G,Temenoff Johnna S.Formation of highly porous biodegradable scaffolds for tissue engineering[J].Biotechnology of Human Disorders,2000,3(2):114-119.
-
9Yang F,Murugan R,Wang S,et al.Electrospinning of nano/micro scale poly(l-lactic acid) aligned fibers and their potential in neural tissue engineering,Biomaterials,2005,26(15):2603-2610.
-
10Solchaga LA,Temenoff JS,Gao J,et al.Repair of osteochondral defects with hyaluronan and polyester-based scaffolds[J].Osteoarthritis Cartilage,2005,13 (4):297-309.
-
1张钧寿,王毅,楼金芳.尼莫地平制剂技术的研究[J].中国新药杂志,1997,6(S1):8-10.
-
2张钧寿,张煊,范敏华,赖树清.尼莫地平胶囊相对生物利用度的研究[J].中国新药杂志,1997,6(S1):5-8. 被引量：3
-
3施孝金,王宏图,韦阳,张静华,张莉莉,钟明康.国产尼莫地平片和尼莫通片的生物利用度比较[J].药学学报,1997,32(9):708-710. 被引量：28
-
4赵杰,阚全程,刘维春.尼莫地平健康人体药动学和相对生物利用度研究[J].医药论坛杂志,2004,25(15):23-24. 被引量：1
-
5蔡俊安,乔立新,李妙芬.尼莫地平胶囊的处方筛选[J].中国医药工业杂志,2000,31(2):69-70. 被引量：2
-
6胡万华.尼莫地平胶囊与尼莫地平片治疗脑动脉硬化症的比较[J].内蒙古医学杂志,1997,29(4):229-230.
-
7郭联庆,谈恒山.尼莫地平胶囊与片剂在8名中国健康人体内的药物动力学与相对生...[J].中国药理学报,1993,14(4):295-297. 被引量：3
-
8王海旭,刘北林,陈友兰,迪力拜尔.盐酸莫西沙星片治疗下呼吸道感染30例临床分析[J].新疆医学,2005,35(6):71-72. 被引量：1
-
9朱胜平,彭向东,邹建军,程泽能,许树梧.高效液相色谱-质谱联用法研究两种尼莫地平制剂的生物等效性[J].中国医院药学杂志,2005,25(2):109-111. 被引量：7
-
10熊岸冰,刘伟卿,邹建军.HPLC-MS法对两种尼莫地平制剂的生物等效性的研究[J].海峡药学,2009,21(3):85-87.
